Oruka Therapeutics, Inc. of MENLO PARK, CA filed a 425 with the SEC on 2024-08-15. Industry: Pharmaceutical Preparations.
| Seq | Type | Description |
|---|---|---|
| 1 | 425 | CURRENT REPORT |
| 2 | EX-10.1 | ASSET PURCHASE AGREEMENT, DATED AUGUST 14, 2024, BY AND BETWEEN ARCA BIOPHARMA, INC. AND GENVARA BIOPHARMA, INC |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-04-17 | DEFA14A |
| 2026-04-17 | DEF 14A |
| 2025-04-18 | DEFA14A |
| 2025-04-18 | DEF 14A |
| 2024-10-18 | DEF 14A |
| 2024-10-07 | PRE 14A |
| 2024-08-27 | 425 |
| 2024-08-16 | 425 |
| 2024-08-15 | 425 |
| 2024-08-09 | 425 |
| 2024-08-01 | 425 |
| 2024-07-09 | 425 |